{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T19:11:22Z","timestamp":1780686682341,"version":"3.54.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rapidly evolved into a pandemic \u2013the likes of which has not been experienced in 100 years. While novel vaccines show great efficacy, and therapeutics continue to be developed, the persistence of disease, with the concomitant threat of emergent variants, continues to impose massive health and socioeconomic issues worldwide. Studies show that in susceptible individuals, SARS-CoV-2 infection can rapidly progress toward lung injury and acute respiratory distress syndrome (ARDS), with evidence for an underlying dysregulated innate immune response or cytokine release syndrome (CRS). The mechanisms responsible for this CRS remain poorly understood, yet hyper-inflammatory features were also evident with predecessor viruses within the \u03b2-coronaviridae family, namely SARS-CoV-1 and the Middle East Respiratory Syndrome (MERS)-CoV. It is further known that the spike protein (S) of SARS-CoV-2 (as first reported for other \u03b2-coronaviruses) possesses a so-called <jats:italic>galectin-fold<\/jats:italic> within the N-terminal domain of the S1 subunit (S1-NTD). This fold (or pocket) shows structural homology nearly identical to that of human galectin-3 (Gal-3). In this respect, we have recently shown that Gal-3, when associated with epithelial cells or anchored to a solid phase matrix, facilitates the activation of innate immune cells, including basophils, DC, and monocytes. A synthesis of these findings prompted us to test whether segments of the SARS-CoV-2 spike protein might also activate innate immune cells in a manner similar to that observed in our Gal-3 studies. Indeed, by immobilizing S components onto microtiter wells, we show that only the S1 subunit (with the NTD) activates human monocytes to produce a near identical pattern of cytokines as those reported in COVID-19-related CRS. In contrast, both the S1-CTD\/RBD, which binds ACE2, and the S2 subunit (stalk), failed to mediate the same effect. Overall, these findings provide evidence that the SARS-CoV-2 spike protein can activate monocytes for cytokines central to COVID-19, thus providing insight into the innate immune mechanisms underlying the CRS and the potential for therapeutic interventions.<\/jats:p>","DOI":"10.3389\/fimmu.2022.831763","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T17:20:00Z","timestamp":1648488000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3"],"prefix":"10.3389","volume":"13","author":[{"given":"John T.","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja P.","family":"Bieneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20200674","article-title":"Immune Asynchrony in COVID-19 Pathogenesis and Potential Immunotherapies","volume":"217","author":"Zhou","year":"2020","journal-title":"J Exp Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103673","article-title":"Complex Immune Deregulation in Severe COVID-19: More Than a Mechanism of Pathogenesis","volume":"73","author":"Giamarellos-Bourboulis","year":"2021","journal-title":"EBioMedicine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.06.009","article-title":"Coronavirus Disease 2019 (COVID-19): Cytokine Storms, Hyper-Inflammatory Phenotypes, and Acute Respiratory Distress Syndrome","volume":"7","author":"Lin","year":"2020","journal-title":"Genes Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.02.029","article-title":"COVID-19 and the Human Innate Immune System","volume":"184","author":"Schultze","year":"2021","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137244","article-title":"Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019","volume":"71","author":"Chen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.681516","article-title":"Cytokine Signature Associated With Disease Severity in COVID-19","volume":"12","author":"Guo","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling Serum Cytokines in COVID-19 Patients Reveals IL-6 and IL-10 are Disease Severity Predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwaa037","article-title":"Elevated Plasma Levels of Selective Cytokines in COVID-19 Patients Reflect Viral Load and Lung Injury","volume":"7","author":"Liu","year":"2020","journal-title":"Natl Sci Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10020-020-00230-x","article-title":"IP-10 and MCP-1 as Biomarkers Associated With Disease Severity of COVID-19","volume":"26","author":"Chen","year":"2020","journal-title":"Mol Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.immuni.2021.05.006","article-title":"SARS-CoV-2 Exacerbates Proinflammatory Responses in Myeloid Cells Through C-Type Lectin Receptors and Tweety Family Member 2","volume":"54","author":"Lu","year":"2021","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03569-1","article-title":"A Molecular Single-Cell Lung Atlas of Lethal COVID-19","volume":"595","author":"Melms","year":"2021","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological Inflammation in Patients With COVID-19: A Key Role for Monocytes and Macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720109","article-title":"Monocytes and Macrophages in COVID-19","volume":"12","author":"Knoll","year":"2021","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.576622","article-title":"The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens","volume":"11","author":"Duan","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15651","article-title":"The Structural Basis of Accelerated Host Cell Entry by SARS-CoV-2dagger","volume":"288","author":"Seyran","year":"2021","journal-title":"FEBS J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, Function, and Evolution of Coronavirus Spike Proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198058","article-title":"Role of the GTNGTKR Motif in the N-Terminal Receptor-Binding Domain of the SARS-CoV-2 Spike Protein","volume":"286","author":"Behloul","year":"2020","journal-title":"Virus Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.12688\/f1000research.25979.2","article-title":"Immunopathology of Galectin-3: An Increasingly Promising Target in COVID-19","volume":"9","author":"Caniglia","year":"2020","journal-title":"F1000Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02069","article-title":"Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider","volume":"11","author":"Garcia-Revilla","year":"2020","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cellimm.2015.01.017","article-title":"Downregulating Galectin-3 Inhibits Proinflammatory Cytokine Production by Human Monocyte-Derived Dendritic Cells via RNA Interference","volume":"294","author":"Chen","year":"2015","journal-title":"Cell Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700055","article-title":"Activation of Human Basophils by A549 Lung Epithelial Cells Reveals a Novel IgE-Dependent Response Independent of Allergen","volume":"199","author":"Schroeder","year":"2017","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.03.001","article-title":"Galectin-3 Is Essential for IgE-Dependent Activation of Human Basophils by A549 Lung Epithelial Cells","volume":"144","author":"Schroeder","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.524826","article-title":"Epithelial Cell-Associated Galectin-3 Activates Human Dendritic Cell Subtypes for Pro-Inflammatory Cytokines","volume":"11","author":"Schroeder","year":"2020","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im0724s112","article-title":"Isolation of Human Basophils","volume":"112","author":"Schroeder","year":"2016","journal-title":"Curr Protoc Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1038\/s41467-021-23494-1","article-title":"SARS-CoV-2 RNAemia and Proteomic Trajectories Inform Prognostication in COVID-19 Patients Admitted to Intensive Care","volume":"12","author":"Gutmann","year":"2021","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: A New Virus, But a Familiar Receptor and Cytokine Release Syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009576","article-title":"Dc\/L-SIGN Recognition of Spike Glycoprotein Promotes SARS-CoV-2 Trans-Infection and Can Be Inhibited by a Glycomimetic Antagonist","volume":"17","author":"Thepaut","year":"2021","journal-title":"PloS Pathog"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd3072","article-title":"Neuropilin-1 Is a Host Factor for SARS-CoV-2 Infection","volume":"370","author":"Daly","year":"2020","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 Facilitates SARS-CoV-2 Cell Entry and Infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.151159","article-title":"The Galectin Lattice at a Glance","volume":"128","author":"Nabi","year":"2015","journal-title":"J Cell Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/0162-3109(93)90034-n","article-title":"Expression and Function of an IgE-Binding Animal Lectin (Epsilon BP) in Mast Cells","volume":"26","author":"Liu","year":"1993","journal-title":"Immunopharmacology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/cimm.1994.1148","article-title":"Activation of Rat Basophilic Leukemia Cells by Epsilon BP, an IgE-Binding Endogenous Lectin","volume":"156","author":"Zuberi","year":"1994","journal-title":"Cell Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-Spike Protein Is a Novel Route for SARS-CoV-2 Infection to Host Cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25444","article-title":"Regulation of the Expression of Heparan Sulfate 3-O-Sulfotransferase 3b (HS3ST3B) by Inflammatory Stimuli in Human Monocytes","volume":"117","author":"Sikora","year":"2016","journal-title":"J Cell Biochem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.03.022","article-title":"Regulation of EMMPRIN (CD147) on Monocyte Subsets in Patients With Symptomatic Coronary Artery Disease","volume":"135","author":"Sturhan","year":"2015","journal-title":"Thromb Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445303","article-title":"IL-3 Synergizes With Basophil-Derived IL-4 and IL-13 to Promote the Alternative Activation of Human Monocytes","volume":"45","author":"Borriello","year":"2015","journal-title":"Eur J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-020-00342-z","article-title":"IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy","volume":"34","author":"Atal","year":"2020","journal-title":"Pharmaceut Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26038","article-title":"Clinical Outcomes in COVID-19 Patients Treated With Tocilizumab: An Individual Patient Data Systematic Review","volume":"92","author":"Antwi-Amoabeng","year":"2020","journal-title":"J Med Virol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00081-3","article-title":"Tocilizumab Plus Standard Care Versus Standard Care in Patients in India With Moderate to Severe COVID-19-Associated Cytokine Release Syndrome (COVINTOC): An Open-Label, Multicentre, Randomised, Controlled, Phase 3 Trial","volume":"9","author":"Soin","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.it.2020.10.012","article-title":"A Potential Role of Interleukin 10 in COVID-19 Pathogenesis","volume":"42","author":"Lu","year":"2021","journal-title":"Trends Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13429","article-title":"Deciphering the COVID-19 Cytokine Storm: Systematic Review and Meta-Analysis","volume":"51","author":"Mulchandani","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666223","article-title":"Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis","volume":"12","author":"Zawawi","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.831763\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T17:20:05Z","timestamp":1648488005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.831763\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2022.831763"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.831763","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"article-number":"831763"}}